Cue Biopharma
CUE
Cue Biopharma (CUE) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$2.70
- EPS estimate
- −$3.90
- EPS surprise
- +30.77%
- Revenue surprise
- +47.70%
- Revenue
- $3.0M
- Revenue estimate
- $2.0M
- Reported
- Aug 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 12, 2025 | −$3.90 | −$2.70 | +30.77% | $3.0M | SEC |
| Q1 2025 | May 12, 2025 | −$4.60 | −$5.10 | −10.87% | $421,000.00 | SEC |
| Q4 2024 | Mar 31, 2025 | −$2.58 | −$3.90 | −51.16% | $1.6M | SEC |
| Q3 2024 | Nov 14, 2024 | −$5.48 | −$5.10 | +6.85% | $3.3M | SEC |
| Q2 2024 | Aug 14, 2024 | −$8.40 | −$6.00 | +28.57% | $2.7M | SEC |
| Q1 2024 | May 9, 2024 | −$8.46 | −$7.50 | +11.35% | $1.7M | SEC |
| Q4 2023 | Mar 28, 2024 | −$9.00 | −$8.40 | +6.67% | $1.8M | SEC |
| Q2 2023 | Aug 8, 2023 | −$9.15 | −$8.70 | +4.92% | $1.4M | SEC |
| Q1 2023 | May 9, 2023 | −$8.33 | −$8.70 | −4.50% | $187,000.00 | SEC |
| Q4 2022 | Mar 21, 2023 | −$8.85 | −$11.10 | −25.42% | $151,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$11.30 | −$9.30 | +17.70% | $68,000.00 | — |
| Q2 2022 | Aug 4, 2022 | −$11.70 | −$11.10 | +5.13% | $26,000.00 | — |
| Q1 2022 | May 10, 2022 | −$12.08 | −$13.20 | −9.32% | $1.0M | — |
| Q4 2021 | Mar 16, 2022 | −$12.66 | −$7.80 | +38.39% | $8.3M | — |
| Q3 2021 | Nov 9, 2021 | −$11.55 | −$12.30 | −6.49% | $2.4M | — |
| Q1 2020 | May 7, 2020 | −$10.02 | −$14.40 | −43.71% | $900,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Cue Biopharma (CUE) last report earnings?
Cue Biopharma last reported on Aug 12, 2025, covering fiscal Q2 2025.
Did CUE beat earnings estimates?
Yes. Cue Biopharma reported EPS of −$2.70 for Q2 2025 against a −$3.90 estimate — a 30.77% beat.
How much revenue did CUE report last quarter?
Cue Biopharma reported $3.0M in revenue for Q2 2025, against a consensus estimate of $2.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.